IF Bancorp (NASDAQ:IROQ) reported quarterly earnings of $0.62 per share. This is a 1.64 percent increase over earnings of $0.61 per share from the same period last year.
Israel-Based Clearmind Medicine Shows Efficacy Of Psychedelic Derived Obesity Treatment In Pre-Clinical Trial
In a series of pre-clinical trials, Clearmind's drug candidate MEAI significantly reduced body weight, improved fatty liver disease, and normalized insulin sensitivity
Tel Aviv, Israel / Vancouver, Canada, Jan.
